AstraZeneca spends up to $1.9B for new heart disease drug - Cardiovascular Business

Retrieved on: 2024-10-07 20:28:44

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca spends up to $1.9B for new heart disease drug - Cardiovascular Business. View article details on hiswai:

Excerpt

AstraZeneca is paying up to $1.9 billion to license a new cardiovascular medication from CSPC Pharmaceutical Group. The company will start by ...

Article found on: cardiovascularbusiness.com